The antibiotics mentioned and frequency with which they were mentioned for the top five indications where antibiotics are said to be prescribed for use in cats.
| Therapeutic Area | Percentage mentioned* | Percentage critically important antibiotics (CIAs) v percentage other antibiotics used for treatment | Frequency of use of the different classes of antibiotics (top 5) |
|---|---|---|---|
Skin diseases including:
| 42% (39%) (3%) | CIAs: 24% Non-CIAs: 76% | Penicillins 51%, 3rd and 4th generation cephalosporins 16%, Lincosamides 11%, (Fluoro)quinolones 8%, 1st and 2nd generation cephalosporins 8% |
| Respiratory disease | 24% | CIAs: 16% Non-CIAs: 84% | Tetracyclines 50%, Penicillins 28%, (Fluoro)quinolones 11%, 1st and 2nd generation cephalosporins 4%, 3rd and 4th generation cephalosporins 3% |
| Urinary tract infection | 16% | CIAs: 62% Non-CIAs: 38% | (Fluoro)quinolones 49%, Penicillins 25%, 3rd and 4th generation cephalosporins 13%, 1st and 2nd generation cephalosporins 9% (Remaining classes 1% or less) |
| Periodontal disease | 14% | CIAs: 38% Non-CIAs: 62% | Penicillins 21%, 3rd and 4th generation cephalosporins 21%, Lincosamides 19%, Macrolides 14%, Metronidazole 12% |
| Perioperative | 1% | CIAs: 19% Non-CIAs: 81% | Penicillins 75%, 3rd and 4th generation cephalosporins 9%, (Fluoro)quinolones 9%, Aminoglycosides 6% (no other classes cited) |
| Other | 3% | CIAs: 25% Non-CIAs: 75% | Penicillins 41%, (Fluoro)quinolones 15%, Metronidazole 10%, 3rd and 4th generation cephalosporins 8%, 1st and 2nd generation cephalosporins 7% |
*Percentages in brackets are part of the percentage mentioned of each therapeutic area.